Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.39
+0.43 (4.80%)
At close: Mar 9, 2026, 4:00 PM EDT
9.35
-0.04 (-0.43%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Kura Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-278.67-173.98-152.63-135.84-130.47
Upgrade
Depreciation & Amortization
1.030.850.850.760.56
Upgrade
Loss (Gain) From Sale of Investments
-8.49-13.14-9.421.614.39
Upgrade
Stock-Based Compensation
37.1133.928.0826.3223.58
Upgrade
Other Operating Activities
0.520.520.480.070.61
Upgrade
Change in Accounts Receivable
-6.74-2.06---
Upgrade
Change in Inventory
-0.41----
Upgrade
Change in Accounts Payable
4.5-1.63-0.92-0.8-2.52
Upgrade
Change in Unearned Revenue
195.72278.18---
Upgrade
Change in Other Net Operating Assets
-8.6211.688.74-2.18-0.71
Upgrade
Operating Cash Flow
-64.06134.32-124.82-110.06-104.55
Upgrade
Capital Expenditures
-6.64-0.47-0.17-0.63-1.15
Upgrade
Investment in Securities
-6.46-101.1215.7333.25-125.69
Upgrade
Investing Cash Flow
-13.1-101.5915.5632.63-126.84
Upgrade
Long-Term Debt Issued
---10-
Upgrade
Long-Term Debt Repaid
-----7.25
Upgrade
Net Debt Issued (Repaid)
---10-7.25
Upgrade
Issuance of Common Stock
1.79154.4294.7829.144.43
Upgrade
Other Financing Activities
----0.58-0.61
Upgrade
Financing Cash Flow
1.79154.4294.7838.57-3.44
Upgrade
Net Cash Flow
-75.36187.14-14.48-38.87-234.82
Upgrade
Free Cash Flow
-70.7133.85-124.99-110.69-105.7
Upgrade
Free Cash Flow Margin
-104.76%248.40%---
Upgrade
Free Cash Flow Per Share
-0.811.55-1.71-1.65-1.59
Upgrade
Cash Interest Paid
11.11.060.070.78
Upgrade
Levered Free Cash Flow
-141.73-55.93-63.9-63.67-60.41
Upgrade
Unlevered Free Cash Flow
-140.78-54.92-62.93-63.53-60.15
Upgrade
Change in Working Capital
184.44286.177.82-2.98-3.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.